Jan 8, 2013, 06:55 AM by Michael Croft

Bio-IT World | The two giants of next-generation sequencing technology, Illumina and Life Technologies, have announced rival initiatives with leading medical institutions in Boston to further the integration of their technology into the clinical genomics arena. Life is investing in Claritas Genomics with Boston Children's Hospital, while Illumina announced the founding members of the GeneInsight-Illumina Network.

Jan 7, 2013, 15:00 PM by Michael Croft

Wall Street Journal Blogs | Data scientists need to have a hybrid set of IT skills, says one big data professional. In a shift from big data (focus on the data) to data science (focus on the science), data-science-oriented disciplines like information-based medicine aim to leverage all sources of data to develop new scientific methods of inquiry.

Jan 7, 2013, 09:00 AM by Michael Croft

Bio-IT World | The pharmaceutical industry could use a fortuneteller. According to a March 2010 issue of Nature Reviews Drug Discovery, drug companies spend on average $1.8 billion dollars to bring a new therapy to market, and that number is estimated to increase in the coming years. This staggering figure is due in part to the lack of predictive algorithms.

Jan 7, 2013, 09:00 AM by Michael Croft

Pittsburgh Business Times | The University of Pittsburgh Schools of Health Services is launching a new Institute of Personalized Medicine to use genetics, genomics and related information from other disciplines to advance evidence-based medicine, practices and procedures that have been proven effective.

Jan 7, 2013, 08:00 AM by Michael Croft

Jan 4, 2013, 13:00 PM by Michael Croft

eWeek | 2013 will look better, but the tech market will fully rebound in 2014, a report from Forrester predicts. Cloud computing will continue to grow, along with mobility and smart computing.

Jan 4, 2013, 13:00 PM by Michael Croft

Jan 4, 2013, 08:00 AM by Michael Croft

News Brief | Biogen Idec has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the marketing approval of a treatment for hemophilia B.

Jan 4, 2013, 08:00 AM by Michael Croft

Bloomberg | The Wellcome Trust has started an investment arm with 200 million pounds ($326 million) of initial capital for biotech. Syncona Partners will support new businesses in the medical-device, therapeutics, diagnostics and information-technology industries.

Jan 4, 2013, 07:00 AM by Michael Croft

Bio-IT World | It all began five years ago when Anne Morriss, an economic development consultant, and her partner decided to use a sperm bank to conceive a child. They studiously reviewed the profiles of hundreds of potential donors, but genetics was an afterthought. “We chose a wonderful donor,” says Morriss, “but he was a carrier for a rare Mendelian disorder called MCADD.” Unbeknownst to Morris, she was a carrier too.   

Jan 3, 2013, 14:00 PM by Michael Croft

Discover Magazine | Researchers were able to turn off the agouti gene in mice--responsible for making most carrier mice overweight and prone to diabetes and cancer--with maternal diet.

Jan 3, 2013, 12:00 PM by Michael Croft

Forbes | NPS Pharmaceuticals is pricing Gattex, its drug for short bowel syndrome, at $295,000 per patient per year. How did they arrive at that number?

Jan 3, 2013, 11:00 AM by Michael Croft

Computerworld | Gartner says that cloud storage is a viable alternative to traditional options, but not all providers can meet the needs of enterprise IT.

Jan 2, 2013, 13:00 PM by Michael Croft

Bloomberg | FDA closed a record year this week; US drug approvals in 2012 reached their highest level in 15 years. The Food and Drug Administration cleared 39 novel medicines last year.

Jan 2, 2013, 12:00 PM by Michael Croft

Wall Street Journal | At the intersection of medicine and technology, six innovations are poised to transform medicine: growing a heart, DNA sequencing in the clinic, matching tumors to drugs, smartphone health care, gene therapy, and more.

Jan 2, 2013, 11:00 AM by Michael Croft

Fort Mills Times | Omicia (a 2012 Bio-IT World Best Practices awards winner) has appointed Mike Aicher as CEO.

Jan 2, 2013, 08:00 AM by Michael Croft

Jan 2, 2013, 07:00 AM by Michael Croft

New York Times | The U.S. Government has granted national security clearance to the BGI-Complete Genomics deal. The Committee on Foreign Investment in the United States, which reviews the national security implications of foreign takeovers of American companies, gave its approval to the deal over the weekend.

Dec 28, 2012, 10:00 AM by Michael Croft

Dec 28, 2012, 08:00 AM by Michael Croft

Boston Business Journal | Parexel has acquired Liquent, a provider of regulatory information management software, for $72 million. Parexel says the acquisition will give its clients access to Liquent's InSight software.